Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) Return on Equity (2016 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Return on Equity for 12 consecutive years, with 1.46% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Equity fell 68.0% to 1.46% in Q4 2025 year-over-year; TTM through Dec 2025 was 1.46%, a 68.0% decrease, with the full-year FY2025 number at 1.25%, down 41.0% from a year prior.
  • Return on Equity was 1.46% for Q4 2025 at Ekso Bionics Holdings, down from 1.09% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.3% in Q2 2021 to a low of 1.46% in Q4 2025.
  • A 5-year average of 0.76% and a median of 0.82% in 2024 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: surged 538bps in 2021, then plummeted -68bps in 2025.
  • Ekso Bionics Holdings' Return on Equity stood at 0.37% in 2021, then crashed by -59bps to 0.58% in 2022, then tumbled by -90bps to 1.11% in 2023, then increased by 30bps to 0.78% in 2024, then tumbled by -87bps to 1.46% in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Return on Equity are 1.46% (Q4 2025), 1.09% (Q3 2025), and 1.06% (Q2 2025).